[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

EA200701300A1 - Амидное пролекарство гемцитабина, композиции на его основе и его применение - Google Patents

Амидное пролекарство гемцитабина, композиции на его основе и его применение

Info

Publication number
EA200701300A1
EA200701300A1 EA200701300A EA200701300A EA200701300A1 EA 200701300 A1 EA200701300 A1 EA 200701300A1 EA 200701300 A EA200701300 A EA 200701300A EA 200701300 A EA200701300 A EA 200701300A EA 200701300 A1 EA200701300 A1 EA 200701300A1
Authority
EA
Eurasian Patent Office
Prior art keywords
compositions
hemcitabin
amida
medication
basis
Prior art date
Application number
EA200701300A
Other languages
English (en)
Other versions
EA011868B1 (ru
Inventor
Дэвид Майкл Бендер
Дэвид Майкл Ремик
Original Assignee
Эли Лилли Энд Компани
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Эли Лилли Энд Компани filed Critical Эли Лилли Энд Компани
Publication of EA200701300A1 publication Critical patent/EA200701300A1/ru
Publication of EA011868B1 publication Critical patent/EA011868B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • C07H19/073Pyrimidine radicals with 2-deoxyribosyl as the saccharide radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Virology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

Данное изобретение относится к новым амидным пролекарствам гемцитабина, композициям на их основе и способам их применения.
EA200701300A 2004-12-17 2005-11-30 Амидное пролекарство гемцитабина, композиции на его основе и его применение EA011868B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63742204P 2004-12-17 2004-12-17
PCT/US2005/043125 WO2006065525A1 (en) 2004-12-17 2005-11-30 Amide prodrug of gemcitabine, compositions and use thereof

Publications (2)

Publication Number Publication Date
EA200701300A1 true EA200701300A1 (ru) 2007-10-26
EA011868B1 EA011868B1 (ru) 2009-06-30

Family

ID=36168678

Family Applications (1)

Application Number Title Priority Date Filing Date
EA200701300A EA011868B1 (ru) 2004-12-17 2005-11-30 Амидное пролекарство гемцитабина, композиции на его основе и его применение

Country Status (31)

Country Link
US (1) US7691827B2 (ru)
EP (1) EP1831237B1 (ru)
JP (1) JP5022911B2 (ru)
KR (1) KR100874052B1 (ru)
CN (1) CN101080417B (ru)
AR (1) AR055009A1 (ru)
AT (1) ATE405573T1 (ru)
AU (1) AU2005316922B2 (ru)
BR (1) BRPI0519117A2 (ru)
CA (1) CA2589850C (ru)
CY (1) CY1108447T1 (ru)
DE (1) DE602005009255D1 (ru)
DK (1) DK1831237T3 (ru)
EA (1) EA011868B1 (ru)
ES (1) ES2310860T3 (ru)
HR (1) HRP20080529T3 (ru)
IL (1) IL183666A (ru)
MA (1) MA29154B1 (ru)
MX (1) MX2007007228A (ru)
MY (1) MY143677A (ru)
NO (1) NO20073368L (ru)
NZ (1) NZ554732A (ru)
PE (1) PE20060771A1 (ru)
PL (1) PL1831237T3 (ru)
PT (1) PT1831237E (ru)
RS (1) RS50629B (ru)
SI (1) SI1831237T1 (ru)
TW (1) TWI326687B (ru)
UA (1) UA86119C2 (ru)
WO (1) WO2006065525A1 (ru)
ZA (1) ZA200705019B (ru)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2446092T3 (es) 2006-06-21 2014-03-06 Eli Lilly And Company Formas cristalinas del profármaco amida gemcitabina, composiciones y uso de las mismas
TWI436775B (zh) 2007-08-24 2014-05-11 Oncotherapy Science Inc 以抗原胜肽合併化療藥劑治療胰臟癌
CN101525361B (zh) * 2009-04-21 2010-11-17 济南圣鲁金药物技术开发有限公司 基于吉西他滨结构的前药及其合成方法及应用
GB0907551D0 (en) 2009-05-01 2009-06-10 Univ Dundee Treatment or prophylaxis of proliferative conditions
CN102432654A (zh) * 2011-09-26 2012-05-02 宋云龙 吉西他滨酰胺衍生物及其制备方法和用途
CA2890359A1 (en) 2012-11-07 2014-05-15 Zucai SUO Substituted gemcitabine aryl amide analogs and treatment methods using same
BR112015010941A2 (pt) 2012-11-13 2017-07-11 Boyen Therapeutics Inc pró-fármacos de gemcitabina e suas utilizações
US10059733B2 (en) 2014-03-03 2018-08-28 Nucorion Pharmaceuticals, Inc. Gemcitabine analogs
WO2016078160A1 (zh) * 2014-11-17 2016-05-26 常州方圆制药有限公司 胞苷衍生物及其应用
US10435429B2 (en) 2017-10-03 2019-10-08 Nucorion Pharmaceuticals, Inc. 5-fluorouridine monophosphate cyclic triester compounds
WO2019139920A1 (en) 2018-01-10 2019-07-18 Nucorion Pharmaceuticals, Inc. Phosphor(n)amidatacetal and phosph(on)atalcetal compounds
US11427550B2 (en) 2018-01-19 2022-08-30 Nucorion Pharmaceuticals, Inc. 5-fluorouracil compounds
JP2021512953A (ja) 2018-02-02 2021-05-20 メイベリックス オンコロジー インコーポレイテッド ゲムシタビンモノホスフェートの小分子薬物コンジュゲート
AU2019258590B2 (en) * 2018-04-26 2022-09-08 NanoMed Holdings Pty Ltd Gemcitabine amphiphile prodrugs
CN108864250A (zh) * 2018-05-29 2018-11-23 北京大学 一种FAPα酶敏感的吉西他滨前体药物及其制备方法和应用
AU2019313484A1 (en) * 2018-08-03 2021-02-18 Cellix Bio Private Limited Compositions and methods for the treatment of cancer
EP3999519A4 (en) 2019-07-17 2023-08-16 Nucorion Pharmaceuticals, Inc. CYCLIC DEOXYRIBONUCLEOTIDE COMPOUNDS
KR20230004716A (ko) 2020-04-21 2023-01-06 리간드 파마슈티칼스 인코포레이티드 뉴클레오티드 프로드러그 화합물
PL442924A1 (pl) * 2022-11-23 2024-05-27 Politechnika Śląska Prolek - glikokoniugat pochodny gemcytabiny, jako związek o działaniu przeciwnowotworowym, sposób otrzymywania i zastosowanie

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4526988A (en) * 1983-03-10 1985-07-02 Eli Lilly And Company Difluoro antivirals and intermediate therefor
US4965374A (en) * 1987-08-28 1990-10-23 Eli Lilly And Company Process for and intermediates of 2',2'-difluoronucleosides
YU43193A (sh) * 1992-06-22 1997-01-08 Eli Lilly And Company 2'-deoksi-2',2'-difluoro(4-supstituisani)pirimidinski nukleozidi antivirusnog i antikancerogenog dejstva i međuproizvodi
RU2131880C1 (ru) * 1992-06-22 1999-06-20 Эли Лилли Энд Компани Способ получения обогащенных бета-аномером нуклеозидов
UA67736C2 (ru) * 1997-01-24 2004-07-15 Конфарма Ас Производные гемицитабина
GB2321454A (en) * 1997-01-24 1998-07-29 Norsk Hydro As Gemcitabine esters and amides
US6624142B2 (en) * 1997-12-30 2003-09-23 Enzon, Inc. Trimethyl lock based tetrapartate prodrugs
US5965119A (en) * 1997-12-30 1999-10-12 Enzon, Inc. Trialkyl-lock-facilitated polymeric prodrugs of amino-containing bioactive agents
US6376470B1 (en) * 1999-09-23 2002-04-23 Enzon, Inc. Polymer conjugates of ara-C and ara-C derivatives
EP1567169A4 (en) * 2002-11-04 2009-10-21 Xenoport Inc GEMCITABINE PROMOTERS, THEIR PHARMACEUTICAL COMPOSITIONS AND USES THEREOF
US7846436B2 (en) * 2003-11-28 2010-12-07 Chemgenes Corporation Oligonucleotides and related compounds

Also Published As

Publication number Publication date
KR100874052B1 (ko) 2008-12-12
SI1831237T1 (sl) 2009-02-28
ATE405573T1 (de) 2008-09-15
PL1831237T3 (pl) 2009-01-30
UA86119C2 (ru) 2009-03-25
WO2006065525A1 (en) 2006-06-22
AR055009A1 (es) 2007-08-01
PT1831237E (pt) 2008-09-22
DE602005009255D1 (de) 2008-10-02
JP2008524218A (ja) 2008-07-10
MA29154B1 (fr) 2008-01-02
ES2310860T3 (es) 2009-01-16
ZA200705019B (en) 2008-10-29
HRP20080529T3 (en) 2008-12-31
CN101080417B (zh) 2011-01-19
MY143677A (en) 2011-06-30
HK1109903A1 (en) 2008-06-27
NZ554732A (en) 2010-09-30
NO20073368L (no) 2007-07-16
AU2005316922A1 (en) 2006-06-22
EP1831237B1 (en) 2008-08-20
AU2005316922B2 (en) 2011-08-25
BRPI0519117A2 (pt) 2008-12-23
IL183666A (en) 2011-09-27
TWI326687B (en) 2010-07-01
CY1108447T1 (el) 2014-04-09
CA2589850C (en) 2012-05-01
MX2007007228A (es) 2007-08-14
PE20060771A1 (es) 2006-09-23
EP1831237A1 (en) 2007-09-12
US7691827B2 (en) 2010-04-06
KR20070086308A (ko) 2007-08-27
CA2589850A1 (en) 2006-06-22
CN101080417A (zh) 2007-11-28
JP5022911B2 (ja) 2012-09-12
RS50629B (sr) 2010-06-30
IL183666A0 (en) 2007-09-20
US20090156547A1 (en) 2009-06-18
DK1831237T3 (da) 2008-10-27
TW200634023A (en) 2006-10-01
EA011868B1 (ru) 2009-06-30

Similar Documents

Publication Publication Date Title
EA200701300A1 (ru) Амидное пролекарство гемцитабина, композиции на его основе и его применение
EA201000642A1 (ru) 2'-фтор-2'-дезокситетрагидроуридины в качестве ингибиторов цитидиндеаминазы
CY1117681T1 (el) Ρυθμιστες 2,3-διοξυγενασης ινδολοαμινης και μεθοδοι χρησης αυτων
EA200870514A1 (ru) Ацетиленовые гетероарильные соединения
CY1118454T1 (el) Πρωτοτυποι αναστολεις πυρρολιου της αναγωγασης s-νιτροζογλουταθειονης ως θεραπευτικοι παραγοντες
HRP20070043A2 (hr) Antivirusna sredstva
MX384206B (es) Formulaciones de inhibidores de dpp iv
EA201001680A1 (ru) Соединения бензолсульфонамидтиазола и оксазола
EA200701840A1 (ru) N-сульфонилпирролы и их применение в качестве ингибиторов гистондезацетилазы
EA201170396A1 (ru) 2-оксо-1,2-дигидрохинолиновые модуляторы иммунной функции
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
EA200800321A1 (ru) Ингибиторы гистондеацетилазы
DK1817301T3 (da) Forstærkere af glutamat-receptorer
EA200970428A1 (ru) [f-18]-меченая l-глутаминовая кислота, [f-18]-меченый l-глутамин, их производные и их применение, а также способ их получения
EA201070247A1 (ru) Ингибиторы протеасом
NO20074823L (no) Rasagilin-formuleringer med forbedret innholdsensartethet
EA200701439A1 (ru) Pyy-агонисты и их применение
EA201070039A1 (ru) Спироциклы в качестве ингибиторов 11-бета гидроксилстероиддегидрогеназы типа 1
ATE528989T1 (de) Kristalline feste rasagilin-base
EA201500403A1 (ru) Соединения, активирующие теломеразу, и способы их применения
EA200701396A1 (ru) Триазолофталазины в качестве ингибиторов pde-2
EA200870515A1 (ru) Моноциклические гетероарильные соединения
EA201000814A1 (ru) 5-[(3,3,3-трифтор-2-гидрокси-1-арилпропил)амино]-1h-хинолин-2-оны, способ их получения и их применение в качестве противовоспалительных средств
EA200970818A1 (ru) Гетероциклические соединения, содержащие их композиции и способы их применения
MX373170B (es) Variantes de la familia il-1.

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU